Loading...

425 posters, 1 videos, 9 audios, 8 topics, 53 sessions, 340 authors, 286 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

22nd Annual Pain Medicine Meeting 2023

November 10 - 11, 2023 | New Orleans Marriott | New Orleans, Louisiana, USA

22nd Annual Pain Medicine Meeting 2023 banner

4707

PRACTICE CHARACTERISTICS OF AN OUTPATIENT PAIN MEDICINE CLINIC AT A LARGE CANCER CENTER; A RETROSPECTIVE REVIEW

Poster Presenter

Tyson Jergensen

Part of Topic

Chronic Pain

Practice Characteristics of an Outpatient Pain Medicine Clinic at a Large Cancer Center;
a Retrospective Review

BACKGROUND

•Increased cancer survival with pain in 55% of patients undergoing cancer treatment, 66% of patients with advanced disease, and 39% of patients after curative treatment
•WHO analgesic ladder reserves interventional treatments for after failure of medication management
 
METHODS
•Retrospective chart review of ten clinic days at the Huntsman Cancer Institute’s Pain Medicine outpatient clinic
 
RESULTS
•102 patients, 45.1% female
•Mean age: 56.1 years (SD=14.4)
•Majority of pain directly related to cancer
•27.5% reported pre-existing pain
•10.8% used opioids before cancer diagnosis
•5.9% had a history of substance use disorder
•Pain was characterized as
•Metastatic bone disease (52.0%)
•Neuropathic pain (56.9%)
•Visceral pain (35.3%)
•Chemotherapy-induced peripheral neuropathic   pain (18.6%)
•Post-surgical pain syndrome (18.6%)
•Pain unrelated to cancer (25.5%)
•Cancer-survivor pain (15.7%)
•Management included
•Intrathecal pump implant (19.6%)
•Spine injection (11.8%)
•Neurolytic sympathetic block (7.8%)
•Intraarticular injection (4.9%)
•Neuromodulation (3.8%)
•Kyphoplasty (1%)
•Opioid management was observed in 75%
•Median oral morphine equivalent dose was 38mg/day
•Neuropathic medications were recommended in 52%
•‘Over-the-counter’ analgesics were suggested in 41.2%
22nd Annual Pain Medicine Meeting 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.